Atlas Trials

Insmed Incorporated

47 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Insmed Incorporated

RecordFirmDate
A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants (NCT07765706)Insmed Incorporated2026-08-25
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (NCT07234032)Insmed Incorporated2026-07-20
A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment (NCT07643155)Insmed Incorporated2026-07-14
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) (NCT07481981)Insmed Incorporated2026-06-26
A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy Participants (NCT07102316)Insmed Incorporated2025-08-19
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT06685835)Insmed Incorporated2024-12-16
A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants (NCT06344728)Insmed Incorporated2024-04-30
A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants (NCT06178783)Insmed Incorporated2023-12-27
A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (NCT06013241)Insmed Incorporated2023-10-30
A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants (NCT05965570)Insmed Incorporated2023-07-28
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (NCT05649722)Insmed Incorporated2023-05-11
A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants (NCT05826574)Insmed Incorporated2023-05-10
A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (NCT05176951)Insmed Incorporated2022-12-22
A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment (NCT05517525)Insmed Incorporated2022-10-04
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension (NCT05147805)Insmed Incorporated2022-08-24
A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants (NCT05355935)Insmed Incorporated2022-04-27
A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH) (NCT04791514)Insmed Incorporated2022-03-29
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis (NCT05090904)Insmed Incorporated2021-11-30
A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants (NCT05652257)Insmed Incorporated2021-08-13
A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment (NCT05673603)Insmed Incorporated2021-07-20
Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (NCT04677569)Insmed Incorporated2021-04-01
Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (NCT04677543)Insmed Incorporated2020-12-22
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT04594369)Insmed Incorporated2020-12-01
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants (NCT06091579)Insmed Incorporated2020-09-17
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants (NCT05927597)Insmed Incorporated2019-01-09
Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT03218917)Insmed Incorporated2017-10-31

Track Insmed Incorporated automatically

Every clearance here is in the API, with alerts when new ones post.